Step 1 topics → Endocrine → Congenital Adrenal Hyperplasia (CAH)

Congenital Adrenal Hyperplasia (CAH)

USMLE Step 1 trap: Attributes salt-wasting in 21-hydroxylase deficiency to cortisol deficiency rather than aldosterone deficiency. Salt-wasting in 21-hydroxylase deficiency is caused by aldosterone deficiency (mineralocorticoid deficiency), not cortisol deficiency, because 21-hydroxylase is required for both cortisol and aldosterone synthesis.

Congenital adrenal hyperplasia (CAH) is a group of enzyme deficiencies in the adrenal steroidogenesis pathway that USMLE Step 1 tests heavily — and students consistently confuse 21-hydroxylase deficiency with 11β-hydroxylase deficiency, reversing the blood pressure phenotype because they don't track what accumulates upstream of each block. The core mechanism is always the same: an enzyme block causes substrate to accumulate upstream, ACTH rises due to loss of cortisol feedback, and the adrenal gland hypertrophies while shunting precursors down whatever pathways remain open. Each enzyme deficiency produces a distinct clinical phenotype — you need to predict the electrolytes, blood pressure, and degree of virilization based on where the block sits in the pathway.

The exam hits CAH from multiple angles. Pure recall questions ask you to match enzyme deficiency to lab findings. Application questions give you a newborn with ambiguous genitalia and hyponatremia and ask you to name the enzyme or explain the mechanism. Passage-based questions may give you an adolescent with hypertension and amenorrhea and ask you to work backward to the diagnosis. The tricky part is that students memorize phenotypes without understanding why they occur — which fails on application questions.

The classic trap is blurring the distinctions between subtypes. Students learn that CAH causes virilization and assume all subtypes do — but 17α-hydroxylase deficiency causes sexual infantilism, not virilization. They learn that CAH causes electrolyte problems and assume cortisol is responsible for the salt-wasting — but aldosterone deficiency drives that in 21-hydroxylase deficiency. USMLE Step 1 specifically exploits these exactly-backwards mental models, so understanding the pathway mechanistically is essential.

From real student decks
76%have cards covering this topic
59%have mature cards
1.5median lapses in 14 days

Common misconceptions

Common mistake
Wrong: The hyponatremia and hyperkalemia in 21-hydroxylase deficiency are caused by cortisol deficiency.
Right: Salt-wasting in 21-hydroxylase deficiency is caused by aldosterone deficiency (mineralocorticoid deficiency), not cortisol deficiency, because 21-hydroxylase is required for both cortisol and aldosterone synthesis.
Cortisol deficiency does not cause salt-wasting — that's a mineralocorticoid function, not a glucocorticoid one. In 21-hydroxylase deficiency, the enzyme block sits before both cortisol and aldosterone in the pathway, so aldosterone cannot be synthesized. It's the aldosterone deficiency that causes sodium wasting and potassium retention, leading to hyponatremia and hyperkalemia. Cortisol deficiency contributes to hypotension and hypoglycemia, but the electrolyte crisis is driven by absent mineralocorticoid activity.
Common mistake
Wrong: 11beta-hydroxylase deficiency causes hypotension like 21-hydroxylase deficiency because both block cortisol synthesis.
Right: 11beta-hydroxylase deficiency causes hypertension because the accumulated substrate 11-deoxycorticosterone has potent mineralocorticoid activity, unlike 21-hydroxylase deficiency where mineralocorticoids are also deficient.
Both 11β-hydroxylase and 21-hydroxylase deficiency block cortisol synthesis, but their effects on blood pressure are opposite because of what accumulates upstream. In 21-hydroxylase deficiency, the block is early enough that aldosterone synthesis also fails, causing salt-wasting and hypotension. In 11β-hydroxylase deficiency, the block is downstream of 11-deoxycorticosterone (DOC), so DOC accumulates — and DOC has significant mineralocorticoid activity. This DOC excess causes sodium retention, volume expansion, hypertension, and hypokalemia. Same cortisol deficiency, completely opposite blood pressure phenotype.
Common mistake
Wrong: 17alpha-hydroxylase deficiency causes virilization because it blocks cortisol and shunts precursors toward androgens.
Right: 17alpha-hydroxylase deficiency blocks both cortisol and sex steroid synthesis; precursors are shunted toward mineralocorticoids, causing hypertension and hypokalemia with absent virilization and sexual infantilism.
17α-hydroxylase is required to enter both the cortisol branch and the sex steroid branch of steroidogenesis. When it's blocked, precursors cannot go toward androgens or estrogens — they pile up and shunt toward the only open pathway, which is mineralocorticoid synthesis (aldosterone, corticosterone). The result is excess mineralocorticoid activity (hypertension, hypokalemia) with complete absence of sex steroids. There is no virilization; instead, both sexes present with sexual infantilism, and 46,XY individuals have female external genitalia because testosterone was never made during fetal development.
Common mistake
Wrong: Glucocorticoid replacement in CAH is given solely to replace cortisol deficiency.
Right: Glucocorticoid replacement in CAH serves dual purposes: replacing deficient cortisol and suppressing excess ACTH to reduce androgen overproduction from the blocked pathway.
Giving glucocorticoids only to 'replace cortisol' misses the second and equally important purpose. In CAH, the elevated ACTH is constantly driving precursors down the open pathways — particularly into androgen production — causing progressive virilization, accelerated bone age, and short final height. Glucocorticoid replacement restores negative feedback on the hypothalamic-pituitary axis, suppressing ACTH and thereby reducing androgen overproduction. This is why the dose and timing of glucocorticoid therapy in CAH are carefully titrated: underdosing allows androgen excess to continue, while overdosing causes iatrogenic Cushing syndrome.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Understand the shared mechanism across all CAH subtypes: how an enzyme block raises ACTH, causes adrenal hyperplasia, depletes downstream products, and shunts precursors toward open pathways — and how this framework predicts the clinical findings for any specific enzyme.
  2. Predict the complete phenotype of 21-hydroxylase deficiency: why both cortisol and aldosterone are deficient (salt-wasting, hypotension, hyponatremia, hyperkalemia), why androgens are overproduced (virilization, ambiguous genitalia in females, precocious puberty in males), and why this is the most common CAH subtype.
  3. Distinguish 11β-hydroxylase deficiency from 21-hydroxylase deficiency: both block cortisol and cause virilization via androgen shunting, but 11β-hydroxylase deficiency causes hypertension instead of hypotension because accumulated 11-deoxycorticosterone acts as a potent mineralocorticoid.
  4. Predict the paradoxical phenotype of 17α-hydroxylase deficiency: cortisol and sex steroids are both deficient, precursors shunt toward mineralocorticoids (hypertension, hypokalemia), and sexual infantilism results in both males (46,XY with female external genitalia) and females (primary amenorrhea, no secondary sex characteristics).
  5. Explain the dual rationale for glucocorticoid replacement in CAH: it replaces deficient cortisol and simultaneously suppresses excess ACTH, thereby reducing the androgen overproduction that causes virilization and its consequences.

Can you avoid these mistakes?

A 3-week-old female presents with vomiting, poor feeding, hyponatremia, and hyperkalemia. Genitalia show clitoromegaly and labial fusion. What enzyme is deficient, what two hormones are absent, and what is the mechanism of the electrolyte abnormalities specifically?
Two patients both have virilization and elevated 17-hydroxyprogesterone. Patient A has hypotension and hyperkalemia. Patient B has hypertension and hypokalemia. What explains the different blood pressure phenotypes, and which enzyme deficiency does each patient have?
A 16-year-old phenotypically female patient presents with primary amenorrhea, no breast development, and hypertension. Karyotype returns 46,XY. Serum testosterone is undetectable. What enzyme deficiency explains this presentation, and why does this enzyme's location in the pathway cause sexual infantilism rather than virilization?
A pediatric endocrinologist adjusts the glucocorticoid dose in a child with CAH by monitoring androgen levels in addition to checking for cortisol deficiency symptoms. Explain the two distinct goals of glucocorticoid therapy in CAH that justify monitoring both outcomes.

Related topics

Hypothalamic-Pituitary-Adrenal (HPA) Axis Hypothalamic-Pituitary-Thyroid (HPT) Axis Hypothalamic-Pituitary-Gonadal (HPG) Axis Hormone Signaling (Peptide vs Steroid)

See how your Anki deck covers this topic.

Upload your deck for a free audit →